HPLC Analysis of NNAL in Urine on Ascentis® Express C18 after SPE using SupelMIP® SPE-NNAL
材料
SPE 管或板
CONDITIONS
sample preparation
SPE (Solid Phase Extraction)
sample/matrix
human urine spiked with 60 or 100 pg/mL NNAL
SPE tube/cartridge
SupelMIP SPE - NNAL, 25 mg/10 mL (LRC) (53206-U)
condition
1 mL dichloromethane; 1 mL methanol; 1 mL DI water
sample addition
2 mL (60 pg/mL sample), 5 mL (100 pg/mL sample)
washing
2 x 1 mL DI water, 10 min vacuum; mL toluene; 1 mL toluene:dichloromethane (9:1, v/v); 1 mL toluene:dichloromethane (4:1, v/v), 2 min. vacuum
elution
2 x 1 mL 10% methanol in dichloromethane, apply gentle vacuum between each fraction
eluate post-treatment
evaporate under nitrogen and reconstitute in 0.15 - 0.25 mL mobile phase
column
Ascentis Express C18, 5 cm x 2.1 mm I.D., 2.7 μm particles (581307-U)
mobile phase
[A] 10 mM ammonium acetate; [B] 10 mM ammonium acetate in acetonitrile
flow rate
0.3 mL/min
column temp.
35 °C
detector
MS/MS, MRM Transitions, ESI(+) (210.2/180 and 210.2/93.2 m/z)
injection
20 μL
说明
法律信息
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
SupelMIP is a registered trademark of Sigma-Aldrich Co. LLC